Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep317 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Pancreas-kidney transplantation improves quality of life in type 1 diabetes patients

Dolores Alcántara-Laguna María , Durán-Martínez Manuel , Calleja-Lozano Rafael , Manuel Sánchez-Hidalgo Juan , Ángeles Gálvez-Moreno María

Introduction: Diabetes is increasing its prevalence as an enhancement of treatment options arises and mortality declines. Pancreas transplantation has been postulated as one of them, specifically indicated for cases with end-stage renal failure where kidney transplantation is required besides. It has been analysed whether there is a clinical benefit in terms of quality of life (QoL) in patients undergoing pancreas-kidney transplantation (PKT) compared to dyalisis population or...

ea0014s5.4 | Novel bioactive peptides – lessons from animals | ECE2007

Somatostatin, cortistatin and their new and old receptors: from comparative to translational endocrinology

Castaño Justo P. , Durán-Prado Mario , Vázquez-Martínez Rafael , Martínez-Fuentes Antonio J. , Gahete Manuel D. , Luque Raul M. , Malagón Maria M.

omatostatin, originally isolated from ovine hypothalami in 1973, and cortistatin, identified a decade ago in amphibians and then in human and rodents, are two highly related peptides thought to derive from a common ancestor gene. Owing to their high structural homology, both peptides bind with similar affinity to the five so-called somatostatin receptors (sst1-sst5), and exert virtually undistinguishable effects on several physiological targets, including inhibition of endocri...